AbbVie Sees Strong Demand for Its $10 Billion M&A Bond Sale
Deals·1 article across 1 outlet
Story updated Rewritten when the story materially grows; the wire is checked every 15 minutesAbout this data
Investors flocked to drugmaker AbbVie Inc.’s $10 billion investment-grade bond sale after signs of investor fatigue for new debt to fund artificial intelligence efforts.
The strong demand indicates a robust interest in AbbVie's financing strategy as it seeks to fund its Apogee deal.
AbbVie
Sources
Every quote below is verbatim from the article it is attributed to.
SourceReports the news
“Investors flocked to drugmaker AbbVie Inc.’s $10 billion investment-grade bond sale after signs of investor fatigue for new debt to fund artificial intelligence efforts.”
Bloomberg — AbbVie Sees Strong Demand for Its $10 Billion M&A Bond Sale